Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Barbas

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected miceJ E Crowe, B R Murphy, R M Chanock, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2001
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapyD Shabat, H N Lode, U Pertl, et al.
Clinical & Experimental Metastasis|March 21, 1998
Alphav integrins mediate adhesion and migration of breast carcinoma cell linesN C Wong, B M Mueller, C F Barbas, et al.
AIDS Research and Human Retroviruses|July 1, 1996
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen bindingJ M Binley, H J Ditzel, C F Barbas, et al.
Journal of Virology|July 11, 1998
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodiesN Sullivan, Y Sun, J Binley, et al.
Journal of Molecular Biology|April 4, 1997
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display librariesH J Ditzel, P W Parren, J M Binley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivityC F Barbas, D Hu, N Dunlop, et al.
AIDS (London, England)|June 1, 1995
Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding siteP W Parren, H J Ditzel, R J Gulizia, et al.
The Journal of Biological Chemistry|September 20, 1997
Identification of a region in the integrin beta3 subunit that confers ligand binding specificityE C Lin, B I Ratnikov, P M Tsai, et al.
Analytical Biochemistry|October 24, 1998
The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage librariesM B Zwick, L L Bonnycastle, K A Noren, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected miceJ E Crowe, B R Murphy, R M Chanock, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2001
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapyD Shabat, H N Lode, U Pertl, et al.
Clinical & Experimental Metastasis|March 21, 1998
Alphav integrins mediate adhesion and migration of breast carcinoma cell linesN C Wong, B M Mueller, C F Barbas, et al.
AIDS Research and Human Retroviruses|July 1, 1996
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen bindingJ M Binley, H J Ditzel, C F Barbas, et al.
Journal of Virology|July 11, 1998
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodiesN Sullivan, Y Sun, J Binley, et al.
Journal of Molecular Biology|April 4, 1997
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display librariesH J Ditzel, P W Parren, J M Binley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivityC F Barbas, D Hu, N Dunlop, et al.
AIDS (London, England)|June 1, 1995
Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding siteP W Parren, H J Ditzel, R J Gulizia, et al.
The Journal of Biological Chemistry|September 20, 1997
Identification of a region in the integrin beta3 subunit that confers ligand binding specificityE C Lin, B I Ratnikov, P M Tsai, et al.
Analytical Biochemistry|October 24, 1998
The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage librariesM B Zwick, L L Bonnycastle, K A Noren, et al.
Pageof 10